194 related articles for article (PubMed ID: 36399837)
1. Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis.
Fico G; Isayeva U; De Prisco M; Oliva V; Solè B; Montejo L; Grande I; Arbelo N; Gomez-Ramiro M; Pintor L; Carpiniello B; Manchia M; Vieta E; Murru A
Eur Neuropsychopharmacol; 2023 Jan; 66():30-44. PubMed ID: 36399837
[TBL] [Abstract][Full Text] [Related]
2. Repurposing Psychotropic Agents for Viral Disorders: Beyond Covid.
Golden SR; Rosenstein DL; Belhorn T; Blatt J
Assay Drug Dev Technol; 2021; 19(6):373-385. PubMed ID: 34375133
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer.
Lenze EJ; Reiersen AM; Zorumski CF; Santosh PJ
J Clin Psychiatry; 2023 Mar; 84(3):. PubMed ID: 36946597
[No Abstract] [Full Text] [Related]
5. COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review.
Bonnet U; Juckel G
J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):284-292. PubMed ID: 35420565
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications.
Prasanth MI; Wannigama DL; Reiersen AM; Thitilertdecha P; Prasansuklab A; Tencomnao T; Brimson S; Brimson JM
Sci Rep; 2024 Jun; 14(1):13462. PubMed ID: 38862591
[TBL] [Abstract][Full Text] [Related]
7. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
8. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey.
Mueller JK; Ahrens KF; Bauer M; Baune BT; Borgwardt S; Deckert J; Domschke K; Ellwanger R; Fallgatter A; Frodl T; Gallinat J; Gottschalk R; Grabe HJ; Hasan A; Herpertz SC; Hurlemann R; Jessen F; Kambeitz J; Kircher T; Kornhuber J; Lieb K; Meyer-Lindenberg A; Rupprecht R; Scherbaum N; Schlang C; Schneider A; Schomerus G; Thoma A; Unterecker S; Walter M; Walter H; Reif A; Reif-Leonhard C
Pharmacopsychiatry; 2023 Nov; 56(6):227-238. PubMed ID: 37944561
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis.
Wen W; Chen C; Tang J; Wang C; Zhou M; Cheng Y; Zhou X; Wu Q; Zhang X; Feng Z; Wang M; Mao Q
Ann Med; 2022 Dec; 54(1):516-523. PubMed ID: 35118917
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials.
Vatvani AD; Kurniawan A; Hariyanto TI
Ann Pharmacother; 2023 Dec; 57(12):1389-1397. PubMed ID: 37002592
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluvoxamine on outcomes of nonhospitalized patients with COVID-19: A systematic review and meta-analysis.
Lu LC; Chao CM; Chang SP; Lan SH; Lai CC
J Infect Public Health; 2022 Nov; 15(11):1259-1264. PubMed ID: 36272390
[TBL] [Abstract][Full Text] [Related]
13. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy.
Ogawa Y; Tajika A; Takeshima N; Hayasaka Y; Furukawa TA
CNS Drugs; 2014 Nov; 28(11):989-1003. PubMed ID: 25160685
[TBL] [Abstract][Full Text] [Related]
14. Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis.
Bhuta S; Khokher W; Kesireddy N; Iftikhar S; Beran A; Mhanna M; Patel NJ; Patel M; Burmeister C; Assaly R
Am J Ther; 2022 May-Jun 01; 29(3):e298-e304. PubMed ID: 35383578
[TBL] [Abstract][Full Text] [Related]
15. Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis.
Lee TC; Vigod S; Bortolussi-Courval É; Hanula R; Boulware DR; Lenze EJ; Reiersen AM; McDonald EG
JAMA Netw Open; 2022 Apr; 5(4):e226269. PubMed ID: 35385087
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis.
Ford AC; Luthra P; Tack J; Boeckxstaens GE; Moayyedi P; Talley NJ
Gut; 2017 Mar; 66(3):411-420. PubMed ID: 26567029
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
19. Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders: A Systematic Review and Meta-Analysis.
Kikuchi Y; Shimomura Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988935
[TBL] [Abstract][Full Text] [Related]
20. Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study.
Hoertel N; Sánchez-Rico M; Gulbins E; Kornhuber J; Carpinteiro A; Abellán M; de la Muela P; Vernet R; Beeker N; Neuraz A; Delcuze A; Alvarado JM; Cougoule C; Meneton P; Limosin F;
Transl Psychiatry; 2022 Mar; 12(1):90. PubMed ID: 35241663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
